tiprankstipranks
Trending News
More News >
Outlook Therapeutics (OTLK)
NASDAQ:OTLK

Compare Outlook Therapeutics (OTLK) vs. Competitors

Compare
1,583 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Outlook Therapeutics
$0.52
$34.62M
-77.30%
1 Buy
2 Hold
0 Sell
Moderate Buy
Oramed Pharm
$2.91
$144.88M
3.68
57.69%
Atara Biotherapeutics
$15.79
$32.23M
2.11
-64.89%
1 Buy
1 Hold
0 Sell
Moderate Buy
Whitehawk Therapeutics
$2.79
$136.67M
20.54
-13.89%
1 Buy
2 Hold
0 Sell
Moderate Buy
Celularity
$1.25
$38.35M
-0.39
-39.72%
Adagene
$1.92
$84.84M
-2.98
4.07%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OTLK
Outlook Therapeutics
0.52
-1.71
-76.59%
ORMP
Oramed Pharm
3.69
1.41
61.84%
ATRA
Atara Biotherapeutics
4.62
-1.95
-29.68%
WHWK
Whitehawk Therapeutics
2.79
-0.19
-6.38%
CELU
Celularity
1.29
-1.01
-43.91%
ADAG
Adagene
1.92
0.08
4.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts